» Articles » PMID: 6603844

Dual Effects of Macrolide Antibiotics on Rat Liver Cytochrome P-450. Induction and Formation of Metabolite-complexes: a Structure-activity Relationship

Overview
Date 1983 Aug 1
PMID 6603844
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have shown that the macrolide antibiotics, troleandomycin and erythromycin, are able to induce their own transformation into a metabolite forming an inactivated complex with rat liver cytochrome P-450. This paper reports the results of a study on the effects of several macrolide antibiotics including oleandomycin, erythromycin derivatives, josamycin, methymycin, tylosin, spiramycin and rifampicin, as well as antibiotics of other series, such as tetracycline and lincomycin, on rat liver cytochromes P-450 in vivo and in vitro. Only the antibiotics containing the desosamine and mycaminose amino sugars were able to give the dual effects already found with troleandomycin: induction of cytochrome p-450 and formation of an inhibitory cytochrome P-450--iron--nitrosoalkane metabolite complex in vivo or in vitro. From these studies, it appears that two structural factors are important for a macrolide antibiotic to lead to such effects: the presence of a non-hindered readily accessible N-dimethylamino group and the hydrophobic character of the molecule. These data are discussed in relation to the adverse effects observed during drug associations involving some of these macrolide antibiotics.

Citing Articles

Insights into Nitrosoalkane Binding to Myoglobin Provided by Crystallography of Wild-Type and Distal Pocket Mutant Derivatives.

Herrera V, Charles T, Scott T, Prather K, Nguyen N, Sohl C Biochemistry. 2023; 62(8):1406-1419.

PMID: 37011611 PMC: 10338068. DOI: 10.1021/acs.biochem.2c00725.


Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data.

Thomas L, Birangal S, Ray R, Miraj S, Munisamy M, Varma M Ther Adv Drug Saf. 2021; 12:20420986211041277.

PMID: 34471515 PMC: 8404633. DOI: 10.1177/20420986211041277.


Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation.

Voigt M, Savelsberg C, Jaeger M J Vis Exp. 2018; (138).

PMID: 30124654 PMC: 6126598. DOI: 10.3791/57434.


Evaluation of Strategies for the Assessment of Drug-Drug Interactions Involving Cytochrome P450 Enzymes.

Reinen J, Smit M, Wenker M Eur J Drug Metab Pharmacokinet. 2018; 43(6):737-750.

PMID: 29785610 DOI: 10.1007/s13318-018-0485-7.


Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrate.

Polasek T, Miners J Eur J Clin Pharmacol. 2006; 62(3):203-8.

PMID: 16416302 DOI: 10.1007/s00228-005-0091-x.